Navigation Links
Cytos Biotechnology Ltd Announces the Completion of Patient Enrolment in the On-going Phase 2b Study of CYT003 for the Treatment of Allergic Asthma
Date:10/20/2013

Zurich), Switzerland. The Company is listed according to the Main Standard on the SIX Swiss Exchange Ltd under the symbol CYTN.

http://www.cytos.com

Forward looking statements  This foregoing press release may contain forward-looking statements that include words or phrases such as "would", "can", "expect", "are intended for", "are designed to", or other similar expressions. These forward-looking statements are subject to a variety of significant uncertainties, including scientific, business, economic and financial factors, and therefore actual results may differ significantly from those presented. There can be no assurance that any further therapeutic entities will enter clinical trials, that clinical trial results will be predictive for future results, that therapeutic entities will be the subject of filings for regulatory approval, that any drug candidates will receive marketing approval from the U.S. Food and Drug Administration or equivalent regulatory authorities, or that drugs will be marketed successfully. Against the background of these uncertainties readers should not rely on forward-looking statements. The Company assumes no responsibility to update forward-looking statements or adapt them to future events or developments.


'/>"/>
SOURCE Cytos Biotechnology Ltd
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Cytos Biotechnology Ltd Reports Second Quarter 2013 Financial Results and Recent Developments
2. Cytos Invites to the Annual Shareholders Meeting 2013
3. A*STAR and Cytos Bring Singapores First Influenza Vaccine to Clinical Testing
4. Cytos VLP Platform is Basis for Phase 1 Clinical Trial with Anti-IgE Vaccine
5. CytoSorbents Receives Approximately $400,000 in Non-Dilutive Capital from the Sale of Net Operating Loss Carryovers
6. Cytos Biotechnology Ltd Reports Third Quarter 2012 Financial Results, Recent Development and Outlook
7. NextSource Biotechnology Launches New Strategic Approach to Mitigate Slow-Downs in Manufacturing of Matured Medications in High Demand
8. Goodwin Biotechnology Announces the Appointment of SooYoung S. Lee, PhD as Chief Operating Officer
9. Jeannette R. Jakus, MD, MBA, Awarded American Academy of Dermatology Translational Biotechnology Fellowship
10. TWi Biotechnology Receives Patent Allowance for Its Lead Drug Candidate AC-201 in the United States
11. The Galien Foundation Announces 2013 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology"
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... Biosensors International Group, Ltd. ("Biosensors " or ... a developer, manufacturer and marketer of innovative medical devices, ... ("Q4 FY15") and fiscal full year ended 31 March ... , Q4 FY15: , Total revenue ... of Fiscal Year 2014 ("Q4 FY14") due to licensing ...
(Date:5/27/2015)... 27, 2015  PDL BioPharma, Inc. (PDL) (NASDAQ: ... , the company,s president and chief executive officer, will ... week in New York City.  The presentation, which will ... at 11:30 a.m. EDT. To access the ... to the Company,s website at http://www.pdl.com and ...
(Date:5/27/2015)... International, Inc. (NASDAQ: BDSI ) announced that Dr. Mark ... present at two important upcoming healthcare conferences: ... Time Grand Hyatt, New York City , ... Growth Stock Conference Tuesday, June 9 2:50 PM Central Time (3:50 ... , Dr. Sirgo will be discussing progress with ...
Breaking Medicine Technology:Biosensors Reports Financial Results for Fiscal Year 2015 2Biosensors Reports Financial Results for Fiscal Year 2015 3Biosensors Reports Financial Results for Fiscal Year 2015 4Biosensors Reports Financial Results for Fiscal Year 2015 5Biosensors Reports Financial Results for Fiscal Year 2015 6Biosensors Reports Financial Results for Fiscal Year 2015 7PDL BioPharma to Present at Jefferies 2015 Global Healthcare Conference 2BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference and the William Blair Growth Stock Conference 2BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference and the William Blair Growth Stock Conference 3
... Inc., (IBI), a privately held biopharmaceutical company that ... ophthalmic pharmaceuticals, today announced that Wendy Yee Murahashi, ... as Vice-President, Clinical Development.  Dr. Murahashi will lead ... proprietary Verisome® drug delivery technology. ...
... 2011 Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ... and chief operating officer, is scheduled to present a ... in New York City on Wednesday, December 14th at ... http://photos.prnewswire.com/prnh/20030226/RIGLLOGO ) To access the live ...
Cached Medicine Technology:Icon Appoints Murahashi Vice President, Clinical Development 2
(Date:5/27/2015)... (PRWEB) May 27, 2015 Holly CaSaroll, founder ... on preventing burns, aging and cancer. The skin is the ... daily. Every year more than 3.5 million cases of skin ... percent are caused by the sun's ultraviolet rays (UVR). ... themselves. , 1. Avoid the sun between the ...
(Date:5/27/2015)... May 27, 2015 CRN International, the ... as its new Chief Financial Officer. , Prinner most ... prior to that held financial/operational executive positions at telecom ... Corp., Conversent Communications, Utilicom, and SNET. His accounting ... , At CRN, Prinner will be able to tap ...
(Date:5/27/2015)... Antonio, TX (PRWEB) May 27, 2015 ... “Pass The Torch” Addiction Treatment Scholarship Award. From June ... awarded $10,000 to 50 drug and alcohol addiction treatment ... afford treatment. Scholarships were drawn at random at addiction ... Director for Sky Toxicology, Matt Green said, “Sky Toxicology ...
(Date:5/27/2015)... NC (PRWEB) May 27, 2015 Danish ... “front line” biomarkers that have the potential to help ... here to read the full story that has ... Aalborg University in Aalborg, Denmark say new biomarkers found ... the outlook for patients with malignant mesothelioma . ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 With the ... Studios, editors can quickly and easily add filmic color grades ... CUBE LUT files. , FCPX LUT Cross Processed Plugin can ... to contemporary looks and everything in between. , FCPX LUT ... be used in many different softwares. With the FCPX LUT ...
Breaking Medicine News(10 mins):Health News:In Recognition of National Melanoma Awareness Month, Beauty Guru Details Skin Tips to Prevent Cancer and Premature Aging 2Health News:CRN International Names New Chief Financial Officer 2Health News:Sky Toxicology Reaches Their $500,000 Goal in Drug and Alcohol Addiction Treatment Patient Scholarship Awards 2Health News:Sky Toxicology Reaches Their $500,000 Goal in Drug and Alcohol Addiction Treatment Patient Scholarship Awards 3Health News:New Report Highlights Current and Emerging Biomarkers for Mesothelioma, According to Surviving Mesothelioma 2Health News:Developers at Pixel Film Studios Release FCPX LUT Cross Processed Plugin for Final Cut Pro X 2
... race and/or marital status can factor into the overall ... is the most significant factor impacting overall survival, according ... Symposium in Thoracic Oncology, sponsored by ASTRO, ASCO, IASLC ... Cancer Institute, in 2008 approximately 215,020 new cases of ...
... small tissue samples from patients with lung cancer and ... is now being utilized to better tailor the chemotherapy ... cell lung cancer, according to a study presented at ... by ASTRO, ASCO, IASLC and the University of Chicago., ...
... chemotherapy agents with targeted therapies called monoclonal antibodies ... patients with advanced non-small cell lung cancer according ... Multidisciplinary Symposium in Thoracic Oncology, sponsored by ASTRO, ... combination of bevacizumab and chemotherapy has been shown ...
... study at the U.S. Department of Energy,s (DOE) ... vinyl-GABA, or GVG) blocks drug-seeking behavior in animals ... environment. Specifically, animals pre-treated with vigabatrin lost interest ... had previously been given methamphetamine. The results will ...
... of a metre in size are widely used, for ... also significant amounts of nanoparticles in exhaust emissions. However, ... because only a very small portion of research into ... Nanoparticles have even been dubbed the asbestos of the ...
... Medicare Advantage & Managed Medicaid, Bring,The SCOOTER Store ... Nov. 13 In a move,expanding its partnerships ... with 17 insurance companies that will allow nearly,seven ... mobility equipment,from The SCOOTER Store when power wheelchairs ...
Cached Medicine News:Health News:Chemotherapy plus targeted therapies shows improved survival in advance-stage lung cancer patients 2Health News:Hope for treating relapse to methamphetamine abuse 2Health News:Hope for treating relapse to methamphetamine abuse 3Health News:Nanoparticles trigger cell death? 2Health News:The SCOOTER Store Expands Power Mobility Products, Services to 7 Million Health Plan Members 2
... in two tip styles- the ... staggered eyes, and the angled ... catheter valve options, SAFE-T-VAC and ... with virtually no residual vacuum ...
Catheter Suction 14FR Sterile W/Control Valve...
Rubber bronchial coude catheter, X-ray opaque, one eye, whistle tip....
... Fluidized Therapy: ,Full-length air fluidization ... provides greater comfort and accelerated healing ... can be defluidized to facilitate patient ... and Reverse Trendelenburg. CPR procedures can ...
Medicine Products: